Skip to main content
. Author manuscript; available in PMC: 2022 May 18.
Published in final edited form as: Methods Mol Biol. 2022;2463:53–66. doi: 10.1007/978-1-0716-2160-8_5

Table 2:

Engraftment details for different humanized mice to study human NK cells

Strains IR dose (cGy) Number of hCD34+ cells Time to reconstitution Functional NK cell development
NSG 80 100k ≥12 weeks No
NOG-IL2 250 50k 4 weeks Yes *
NOG-IL15 Unknown Unknown Unknown Unknown
NSG-IL15 80 100k ≥12 weeks Unknown
NSG-IL7-IL15 150 2.5k – 26k ≥12 weeks Yes
SRG 360 100k ≥12 weeks No
SRG-15 360 100k ≥12 weeks Yes *
NSG-SGM3 80 50k 7–8 weeks Unknown
MISTRG 80 or none 10–50k 7–8 weeks Yes *
BRGSF 300 200k 8–9 weeks Yes
*

Studies with these three next-generation humanized mouse stains demonstrated NK cell-mediated killing of tumor cells in vivo (MHC class I-deficient tumor cells and/or ADCC).